An Intensive Monitoring of Adverse Drug Reactions in Indoor Patients of Paediatric Department at Tertiary Care Teaching Hospital in Gujarat, India.
Abstract
they differ from adults in pharmacokinetic and pharmacodynamics responses. ADRs reported in adults do not predict those in children. Thus, this study aimed to intensively monitor ADRs occurred in inpatients of paediatric department of tertiary care teaching hospital to assess the same in terms of incidence, causality, severity and preventability. A prospective observational single centre study was done in the paediatric department of SSG hospital, Vadodara over duration of 8 months. The ADRs were actively monitored and collected reports were analysed for ADR pattern, demographic profile, causality, severity, and preventability. A total of 66 ADRs were documented during the period of 8 months. Among these 53.03% ADRs occurred below the age of 1 year, 89.13% ADRs occurred due to antibiotics, 56.06% ADRs are of Diarrhoea and vomiting and 80.43% ADRs developed after receiving drug intravenously. As per WHO-UMC criteria, 46.96 % ADRs were of probable while 51.51% ADRs were of possible causality while as per Naranjo scale 60.61% ADRs were of probable and 39.39% ADRs were of possible category. As per severity scale 69.70% reactions were mild and 30.30 % reactions were moderate. Probably preventable ADRs were about 57.58%. ADRs occurred more among infants and antibiotics were more commonly implicated. Most of the reactions were of mild severity and were probably preventable. Certain Precautionary measures can lead to significant prevention of ADRs in paediatric patients.
Keywords
Full Text:
PDFReferences
caused by adverse drug reactions: a meta-analysis of observational studies. Pharmacy World & Science.2002;24(2):46-54.
Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalised patients. Journal of the American Medical Association.1997; 277(4):307-11.
Jose J, Rao PG. Pattern of adverse drug reaction notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacological Research.2006;54(3):226-33.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Journal of the American Medical Association.1998; 279(15):1200-5.
Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21(6):623-50.
Murphy BM and Frigo LC. Development, Implementation and Results of a Successful Multidisciplinary Adverse Drug Reaction Reporting Program in a University Teaching Hospital. Hospital Pharmacy. 1993; 28(12):1199-204.
Chien JY, Ho RJ. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. Journal of Pharmaceutical Sciences. 2011;100(1):53–8.
Aagaard L, Hansen EH. Adverse drug Reactions reported for systemic antibacterial in Danish children over a decade. British Journal of Clinical Pharmacology. 2010;70(5):765–8.
Le J, Nguyen T, Law AV, Hodding J. Adverse drug Reactions among children over a 10-year period. Paediatrics. 2006;118(2):555–62
Bavdekar SB, Karande S. National Pharmacovigilance Program. Indian Paediatrics. 2006;43(1):27–32.
Clavenna A, Bonati M. Adverse drug Reactions in childhood: A review of prospective studies and safety alerts. Archives of Disease in Childhood. 2009;94(9):724–8.
Johann-Liang R, Wyeth J, Chen M, Cope JU. Paediatric drug surveillance and the Food and Drug Administration’s adverse event reporting system: An overview of reports, 2003-2007. Pharmacoepidemiology and Drug Safety. 2009;189(1):24–7.
Dikshit RK, Desai CK, Desai MK. Pleasures and pains of running adverse drug reactions in a department of general medicine. Indian Journal of Pharmacology. 2008;40(Suppl 1): 31-4.
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. British Medical Journal. 1998; 316(7140): 1295-8.
Mann RD, Andrews EB. Pharmacovigilance. Second Edition. England: John Willey & Sons Ltd; 2007.
Kaufman G. Adverse drug reactions: classification, susceptibility and reporting. Nursing standard. 1987;30(50),53–63.
Priyadharsini R, Surendiran A, Adithan C, Sreenivasan S, Sahoo FK. A study of adverse drug Reactions in paediatric patients. Journal of Pharmacology & Pharmacotherapeutics. 2011;2(4):277-280.
Sharma PK, Misra AK, Gupta N, Khera D, Gupta A, Khera P. Paediatric pharmacovigilance in an institute of national importance: Journey has just begun. Indian Journal of Pharmacology. 2017;49(5):390-5
World Health Organization (WHO). The use of the WHO-UMC system for standardised case causality assessment. Available at: http://www.who umc.org/graphics/4409.pdf [Accessed on 16 August 2020]
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics. 1981; 30(2):239-45.
Hartwig S, Seigel J, et al.Preventability and severity assessment in reporting adverse drug reactions. Americal Journal of Hospital Pharmacy. 1992; 49(9): 2229-32.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hospital Pharmacy. 1992; 27(6):538.
DOI: https://doi.org/10.15416/pcpr.v6i1.30769
Refbacks
- There are currently no refbacks.
